ABSTRACT
Alzheimer’s disease (AD) affects millions of people worldwide, and early diagnosis is crucial for prompt intervention and therapy. Biomarkers provide valuable information for the diagnosing, prognosis, and treatment of AD by measuring physiological or pathological processes. This chapter discusses various types of biomarkers, such as biochemical, neuroanatomical, metabolic, genetic, neuropsychological, and radio-imaging biomarkers, and their potential impacts on clinical practice and research. The limitations and challenges of biomarker analysis, such as standardization, sensitivity, specificity, and cost-effectiveness, are also discussed. Additionally, the potential of biomarker analysis in developing new treatments and drug discovery for AD is highlighted. This chapter emphasizes the importance and future perspectives of biomarker analysis, its potential to improve millions of lives affected by AD, and its significance in the early detection and management of the disease.
